Theravance Biopharma Inc (0TB) — Capital Reinvestment Ratio

Latest as of March 2018: 0.06x

Theravance Biopharma Inc (0TB) has a Capital Reinvestment Ratio of 0.06x as of March 2018, meaning it reinvests 0% of its operating cash flow (€49.83 Million) in capital expenditures (€2.77 Million). Check Theravance Biopharma Inc (0TB) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.06x

Capex / Operating Cash Flow

Operating Cash Flow

€49.83 Million

EUR

Capital Expenditures

€2.77 Million

EUR

Data as of

Mar 2018

Most recent filing

Annual Capital Reinvestment Ratio for Theravance Biopharma Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Theravance Biopharma Inc from None to None. See Theravance Biopharma Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow